1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, August 2016 (p20)

Biopharmaceutical Analysis & Statistics, August 2016 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

571-600 of about 3 400 reports

Purchase Reports From Reputable Market Research Publishers

EPO Biosimilars - The Future of Erythropoietin Market

EPO Biosimilars - The Future of Erythropoietin Market

  • $ 600
  • Industry report
  • August 2016
  • by RNCOS

Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia ...

  • Industries : Biopharmaceutical
  • Countries : World
Chr Hansen in Ingredients (World)

Chr Hansen in Ingredients (World)

  • $ 570
  • Company report
  • June 2016
  • by Euromonitor International

Chr Hansen is a global market leader in cultures, enzymes and natural colours. After five years of control by a private equity firm, the newly streamlined business returned to public ownership and has ...

  • Industries : Dairy Products, Food
  • Countries : World, Europe, Asia, China, United States
Dupont Nutrition & Health in Ingredients (World)

Dupont Nutrition & Health in Ingredients (World)

  • $ 570
  • Company report
  • June 2016
  • by Euromonitor International

DuPont’s Nutrition & Health division is the amalgamation of three former businesses - Danisco, Solae and Qualicon - and brings together activities in speciality food ingredients, food protection and ...

  • Industries : Food Ingredient, Food Ingredient, Food Manufacturing, Food Manufacturing, Biopharmaceutical
  • Countries : World, Asia, Denmark, China
Kinrix Vaccine (Dtap And Ipv (Polio)) Vaccines: Patent Overview

Kinrix Vaccine (Dtap And Ipv (Polio)) Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

“Combination vaccine with acellular pertussis” ” is titled for one of the patents that was published in 2011. The assignee is Panacea Biotec Limited. There are few more patents recently published. ...

  • Industries : Biopharmaceutical
Hepatitis B  Vaccines: Patent Overview

Hepatitis B Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

“Vaccine Stabilizer" is titled for one of the patents that was published in 2014.The assignee is GE Healthcare Bio-Sciences Corp.This claims a formulation containing trimethylamine-N-oxide that aids ...

  • Industries : Biopharmaceutical
Plant derived protein:Patent Overview

Plant derived protein:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Protein is an essential nutrient that plays a key role in how our bodies function. But too much protein is associated with several diseases. It is more important to eat a varied diet than to isolate and ...

  • Industries : Biopharmaceutical
Enzymes in Meat, Poultry & Seafood Products:Patent Overview

Enzymes in Meat, Poultry & Seafood Products:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Present in plants, animals, and microorganisms, enzymes are proteins that function as catalysts for the thousands of chemical reactions that take place in all living cells. These natural substances are ...

  • Industries : Biopharmaceutical
Enzymes in Oils & Fats:Patent Overview

Enzymes in Oils & Fats:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Present in plants, animals, and microorganisms, enzymes are proteins that function as catalysts for the thousands of chemical reactions that take place in all living cells. These natural substances are ...

  • Industries : Biopharmaceutical
Inactivated Vaccines: Patent Overview

Inactivated Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Inactivated vaccines consist of organisms that have been rendered incapable of replicating, so they cannot cause disease, but maintain the ability to induce a protective immune response. Inactivation o ...

  • Industries : Biopharmaceutical
Intradermal Vaccines: Patent Overview

Intradermal Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Most vaccines are delivered by the intramuscular or subcutaneous routes using a needle and syringe; the intradermal route is only widely used for the administration of Bacille Calmette-Guérin and rabies ...

  • Industries : Biopharmaceutical
Intranasal Vaccines: Patent Overview

Intranasal Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The nasal delivery of vaccines has recently emerged as an attractive alternative to injection. Nasal vaccination has the advantage that it elicits both local and systemic immune responses. The mucosal ...

  • Industries : Biopharmaceutical
Live Attenuated Vaccines: Patent Overview

Live Attenuated Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Live attenuated vaccines are made by weakening the natural virus or bacteria (uncommon). Viruses are so very simple, in that they contain very few genes. It’s because of this that researchers are very ...

  • Industries : Biopharmaceutical
Monovalent Vaccines: Patent Overview

Monovalent Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

A monovalent vaccine is designed to immunize against a single antigen or single microorganism. In certain cases, a monovalent vaccine may be preferable for rapidly developing a strong immune response."Monovalent ...

  • Industries : Biopharmaceutical
Multivalent Vaccines: Patent Overview

Multivalent Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

A multivalent is designed to immunize against two or more strains of the same microorganism, or against two or more microorganisms.”Multivalent Glycoconjugate Vaccines” is titled for one of the patents ...

  • Industries : Biopharmaceutical
Recombinant Vaccines: Patent Overview

Recombinant Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Biotechnology sector has also played its part in developing vaccines against certain diseases. Such vaccine which makes use of recombinant DNA technology is known as recombinant vaccines. It is also known ...

  • Industries : Biopharmaceutical, Therapy
Orally Administered Vaccines: Patent Overview

Orally Administered Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Vaccination is an efficient and cost-effective form of preventing infectious diseases. However, most currently available vaccines are delivered by injection, which makes mass immunization more costly and ...

  • Industries : Biopharmaceutical
Lysine as A Feed Amino Acid in Ruminants:Patent Overview

Lysine as A Feed Amino Acid in Ruminants:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The industrial application of amino acids for feed has an almost 40-year history. In the late 1950s and 1960s, DL-Methionine, produced by chemical synthesis, began finding its way into poultry feed. Production ...

  • Industries : Biopharmaceutical
Proteases in Beverages:Patent Overview

Proteases in Beverages:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Protease (also known as a proteolytic enzyme, peptidase or proteinase) is a type of enzyme that functions mainly to help us digest different kinds of proteins. They break down the bonds by a process known ...

  • Industries : Biopharmaceutical
Vaccine Adjuvants - Patent Overview In The Last Years

Vaccine Adjuvants - Patent Overview In The Last Years

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Adjuvants have been used for decades to improve the immune response to vaccine antigens. They improve the body's immune response and often allow for smaller amounts of an inactivated virus or bacteria ...

  • Industries : Biopharmaceutical
Enzymes in Dairy & Frozen Products:Patent Overview

Enzymes in Dairy & Frozen Products:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Present in plants, animals, and microorganisms, enzymes are proteins that function as catalysts for the thousands of chemical reactions that take place in all living cells. These natural substances are ...

  • Industries : Biopharmaceutical
Chicken pox/Varicella Vaccines: Patent Overview

Chicken pox/Varicella Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

“New method for producing high titer cell-free VZV vaccine virus” is titled for one of the patents that was published in 2014.The applicant is Erasmus University Medical Center Rotterdam.There are ...

  • Industries : Biopharmaceutical
Dendritic Cell Vaccines: Patent Overview

Dendritic Cell Vaccines: Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

“Therapeutic cancer vaccines derived from a novel dendritic cell line” is titled for one of the patents that was published in 2014. The assignee is Dcprime B.V. There are few more patents recently ...

  • Industries : Biopharmaceutical
Proteases in Dairy & Frozen Products:Patent Overview

Proteases in Dairy & Frozen Products:Patent Overview

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Protease (also known as a proteolytic enzyme, peptidase or proteinase) is a type of enzyme that functions mainly to help us digest different kinds of proteins. They break down the bonds by a process known ...

  • Industries : Biopharmaceutical
Biosimilars Market outlook -  Market size, segmentation, market share and competitive landscape (2016-2021)

Biosimilars Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global Biosimilars Market was valued at USD 5237 in 2015 and is forecasted to reach USD 28200.0 million by 2020, growing at a CAGR of 40.3% during the forecast period from 2015 to 2020. A biosimila ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : World
Cancer vaccines Market outlook -  Market size, segmentation, market share and competitive landscape (2016-2021)

Cancer vaccines Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global cancer vaccines market accounted for a market value of USD 4.7 billion in 2015 and is expected to reach USD 4.8 billion by 2016. The market is expected to reach USD 5.3 billion by 2021, growing ...

  • Industries : Biopharmaceutical
  • Countries : World
Therapeutic Vaccines - Patent Overview in the years 2011 - 2016

Therapeutic Vaccines - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Preventive Vaccines are administered to healthy individuals who are free from target infections. Here, a part of the virus or inactive virus or modified microbes is introduced in the body which leads to ...

  • Industries : Biopharmaceutical, Therapy
Preventive Vaccines Market outlook -  Market size, segmentation, market share and competitive landscape (2016-2021)

Preventive Vaccines Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global preventive vaccines market accounted for a market value of USD 30.4 billion in 2015 and is expected to reach USD 33.6 billion by 2016. The market is expected to reach USD 58 billion by 2021, ...

  • Industries : Biopharmaceutical
  • Countries : World
Veterinary Vaccine Market outlook -  Market size, segmentation, market share and competitive landscape (2016-2021)

Veterinary Vaccine Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global veterinary Vaccines market accounted for a market value of USD 12127 million in 2015. The Market has been estimated to be worth USD 13269 million in 2016 and is projected to reach a market value ...

  • Industries : Biopharmaceutical, Therapy
  • Countries : World
Pea Protein - Patent Overview in the years 2011 - 2016

Pea Protein - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Extracted from the yellow pea, Pisum Sativum, pea protein is a food additive, generally used as a dairy alternative and a dietary supplement. It boasts a neutral taste and possesses a typical amino acid ...

  • Industries : Biopharmaceutical
  • Countries : World
Biopharmaceuticals - Patent Overview in the years 2011 - 2016

Biopharmaceuticals - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Biopharmaceuticals are medicinal products produced or extracted from biological sources. They are used in the process of diagnosis and are manufactured from a biological source. The first biopharmaceutical ...

  • Industries : Biopharmaceutical, Biotechnology
About 10 000 reports

Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • August 2016
    13 pages
  • Vaccine  

    HPV Vaccine  

  • United States  

View report >

Protein Industry

August 2016

Enzyme Industry

August 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.